EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 71 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,087,000 | -14.5% | 312,492 | +9.1% | 0.76% | -12.7% |
| Q2 2021 | $2,441,000 | -0.2% | 286,554 | +3.6% | 0.87% | -17.1% |
| Q1 2021 | $2,447,000 | -32.5% | 276,535 | -6.3% | 1.05% | -36.2% |
| Q4 2020 | $3,626,000 | +61.8% | 295,035 | +7.1% | 1.64% | +24.8% |
| Q3 2020 | $2,241,000 | -11.5% | 275,348 | +4.4% | 1.32% | -4.8% |
| Q2 2020 | $2,532,000 | +41.2% | 263,748 | 0.0% | 1.38% | +22.1% |
| Q1 2020 | $1,793,000 | -48.7% | 263,748 | +12.5% | 1.13% | -20.1% |
| Q4 2019 | $3,493,000 | +45.4% | 234,448 | 0.0% | 1.42% | +40.2% |
| Q3 2019 | $2,403,000 | +4.5% | 234,448 | +8.1% | 1.01% | +4.1% |
| Q2 2019 | $2,300,000 | +25.3% | 216,969 | +65.2% | 0.97% | +32.5% |
| Q1 2019 | $1,836,000 | +37.6% | 131,333 | 0.0% | 0.73% | +16.7% |
| Q4 2018 | $1,334,000 | +10.4% | 131,333 | +30.5% | 0.63% | +59.9% |
| Q3 2018 | $1,208,000 | +7.9% | 100,669 | +9.7% | 0.39% | -6.7% |
| Q2 2018 | $1,120,000 | +83.9% | 91,769 | +48.4% | 0.42% | +67.3% |
| Q1 2018 | $609,000 | +98.4% | 61,857 | +181.2% | 0.25% | +105.7% |
| Q4 2017 | $307,000 | +158.0% | 22,000 | +103.7% | 0.12% | +139.2% |
| Q3 2017 | $119,000 | – | 10,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |